Anti-tuberculosis vaccine BCG10
Product Description
Synthaverse S.A.
-
PL
-
2023On CPHI since
-
1Certificates
-
100 - 249Employees
Company types
Primary activities
Categories
Specifications
Synthaverse S.A.
-
PL
-
2023On CPHI since
-
1Certificates
-
100 - 249Employees
Company types
Primary activities
More Products from Synthaverse S.A. (2)
-
Product Distreptaza
Rectal suppositories indicated for:
1) Supportive treatment of pelvic inflammatory disease (PID) – inflammatory diseases of the ovaries, fallopian tubes and endometrium,
2) Adhesions after abdominal surgical procedures,
3) Acute haemorrhoidal disease and chronic haemorr... -
Product Onko BCG 100
BCG for immunotherapy.
The product is intended for treatment of superficial, epithelial non-invasive urothelial carcinomas (carcinoma urotheliale Ta, Tis, T1)
1 ampoule or 1 vial with the powder contains:
Live attenuated bacilli Bacillus Calmette-Guerin, Brazilian BCG Moreau substrain ...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance